A Multi-Center, Double-Masked, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of SUN 131 Transdermal System (TDS) as Compared to Placebo TDS in Adult Patients With a Chalazion

Trial Profile

A Multi-Center, Double-Masked, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of SUN 131 Transdermal System (TDS) as Compared to Placebo TDS in Adult Patients With a Chalazion

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Aug 2017

At a glance

  • Drugs SUN 131 (Primary)
  • Indications Chalazion
  • Focus Therapeutic Use
  • Sponsors Senju Pharmaceutical
  • Most Recent Events

    • 11 Feb 2016 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
    • 09 Dec 2015 Planned End Date changed from 1 Jul 2015 to 1 Jul 2016, according to ClinicalTrials.gov record.
    • 09 Dec 2015 Planned primary completion date changed from 1 Jul 2015 to 1 Jul 2016, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top